You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Low-dose atropine eye drops for treating myopia in people 3 to 14 years [ID6517]

  • In development
  • Reference number: GID-TA11669
  • Expected publication date:  03 September 2026
  • Project information
  • Project documents

On this page

  1. Invitation to participate
  2. Notes
  3. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: ID6517

Documents

Documents created during the development process.

Invitation to participate

  • Final scope (PDF 144 KB)

    Published:
    25 November 2025
  • Final stakeholder list (PDF 142 KB)

    Published:
    25 November 2025
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 393 KB)

    Published:
    25 November 2025
  • Equality impact assessment (scoping) (PDF 124 KB)

    Published:
    25 November 2025

Notes

  • The NICE Prioritisation Board (PB) met on Monday 16 June 2025 to consider the findings of the scoping exercise for this topic. PB subsequently agreed that low-dose atropine eye drops for treating myopia in people 3 to 14 years, should be selected for evaluation and ministerial referral from the Department of Health and Social Care (DHSC) will now b

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: ID6517

  • Draft matrix post referral (PDF 44 KB)

    Published:
    24 March 2025
  • Draft scope post referral (PDF 98 KB)

    Published:
    24 March 2025
Back to top